Pages that link to "Q28547506"
Jump to navigation
Jump to search
The following pages link to Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study (Q28547506):
Displaying 4 items.
- Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors (Q36241010) (← links)
- In-vivo relation between plasma concentration of sorafenib and its safety in Chinese patients with metastatic renal cell carcinoma: a single-center clinical study (Q41092089) (← links)
- A meta-analysis of efficacy and safety of sorafenib versus other targeted agents for metastatic renal cell carcinoma (Q61806172) (← links)
- Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. (Q64965560) (← links)